Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Visual Guide to Scleroderma and Approach to TreatmentLung Involvement in Systemic Sclerosis

A Visual Guide to Scleroderma and Approach to Treatment: Lung Involvement in Systemic Sclerosis [Thoracic manifestations of systemic sclerosis (SSc) are common, occurring in some form in nearly all patients in both limited and diffuse SSc subsets. Most SSc-related mortality is now attributed to end-stage lung disease. All patients with SSc should be screened for the development of ILD and pulmonary hypertension at the time of diagnosis and periodically thereafter. Early diagnosis and appropriate therapy (immunosuppression for ILD and specific vasodilator therapy for pulmonary hypertension) show promise for improved prognosis.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Visual Guide to Scleroderma and Approach to TreatmentLung Involvement in Systemic Sclerosis

Editors: Mayes, Maureen D.
Huggins, John T.; Ravenel, James G.; Silver, Richard M.
Springer Journals — Jun 6, 2014
Download PDF
13 pages

Loading next page...
 
/lp/springer-journals/a-visual-guide-to-scleroderma-and-approach-to-treatment-lung-oZgzzheHCV
Publisher
Springer New York
Copyright
© Springer Science+Business Media New York 2014
ISBN
978-1-4939-0979-7
Pages
63 –75
DOI
10.1007/978-1-4939-0980-3_6
Publisher site
See Chapter on Publisher Site

Abstract

[Thoracic manifestations of systemic sclerosis (SSc) are common, occurring in some form in nearly all patients in both limited and diffuse SSc subsets. Most SSc-related mortality is now attributed to end-stage lung disease. All patients with SSc should be screened for the development of ILD and pulmonary hypertension at the time of diagnosis and periodically thereafter. Early diagnosis and appropriate therapy (immunosuppression for ILD and specific vasodilator therapy for pulmonary hypertension) show promise for improved prognosis.]

Published: Jun 6, 2014

Keywords: Interstitial lung disease; Usual interstitial pneumonia; Nonspecific interstitial pneumonia; Pericardial effusion; Esophagus; Cardiomyopathy; Pulmonary veno-occlusive disease; Pulmonary function test; Forced vital capacity; Diffusing capacity for carbon monoxide

There are no references for this article.